ENDRA Life Sciences (NDRA) Tops Q3 EPS by 1c
ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.
ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.